Art at Noon

About Bill Crouse

Mr. Crouse is the retired Managing Director and a General Partner of Healthcare Ventures, one of the world’s largest venture capital firms specializing in biotechnology. HealthCare Ventures creates, finances, manages and builds high science biopharmaceutical companies. The General Partners have led the strategic development and management of more than 100 companies with a combined market capitalization of greater than $60 billion in important and emerging fields such as genetic therapy, genomic sciences and organ and cellular transplantation. Mr. Crouse maintains extensive contacts with major pharmaceutical and biotechnology companies and has assisted the portfolio companies in initiating and negotiating collaborative agreements which have resulted in more than $3 billion of funding to the portfolio companies. He also led a leveraged buyout of a Johnson & Johnson operating company and served as Chairman until the business was sold to Sybron Corporation.

In addition to his twenty plus years of venture capital experience, he had thirty years of experience in the pharmaceutical and diagnostics industry in general management, international operations, strategic planning, licensing, acquisitions, new product development, and sales and marketing. Prior to joining HealthCare Ventures, he was Worldwide President of Ortho Diagnostic Systems and a Vice President of Johnson & Johnson International from 1987 to 1993.

Before joining Johnson & Johnson, Mr. Crouse was Division Director, DuPont Pharmaceuticals, responsible for all international businesses and worldwide commercial development activities. He previously served as President of Revlon Health Care Group’s companies in Latin America, Canada and Asia/Pacific. He also held various sales, marketing and management positions at E.R. Squibb & Sons and lived and worked in Latin America and Europe for seven years.

Mr. Crouse retired in 2018 from the Board of Directors for The Medicines Company, a publicly traded biotechnology company, where he was Chairman of the Compensation Committee and the Goverance and Nominating Committee. He is currently on the Board of Directors of three private biotechnology companies. Previously he served on the Board of Directors of numerous other biotechnology companies and has recently been involved with the successful sale of EUSA to Jazz Pharmaceuticals, CBR,Inc to GTCR and then to AMAG Pharmaceuticals and Precision Dermatology to Valaent Pharmaceuticals.

Among his community activities, Mr. Crouse served as a Trustee and executive committee member of Lehigh University and is a member of their Business Advisory Board. He is a Trustee and Executive Committee Member Emeritus of the New York Blood Center and served as Chairman of the New Jersey Blood Services Blood Drive. He was a Trustee at Mailman School of Public Health at Columbia University. He is a former Board Member of Liberty Science Center and was on the Board of Trustees and the Executive Committee of the United Way of Somerset County and was co-chairman of their annual fund raising campaign. He also served on the Board of Directors of Pace University, Lubin Graduate School of Business Alumni Association. He was active in the Health Industry Manufacturers Association and the Pharmaceutical Research and Manufacturers Association. He received a B.S. in Finance and Economics from Lehigh University and an M.B.A with Distinction in Marketing Management from Pace University.